224 related articles for article (PubMed ID: 17433371)
1. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents.
Nishimura S; Fukushima O; Ishikura H; Takahashi T; Matsunami M; Tsujiuchi T; Sekiguchi F; Naruse M; Kamanaka Y; Kawabata A
Gut; 2009 Jun; 58(6):762-70. PubMed ID: 19201768
[TBL] [Abstract][Full Text] [Related]
3. Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice.
Kawabata A; Matsunami M; Tsutsumi M; Ishiki T; Fukushima O; Sekiguchi F; Kawao N; Minami T; Kanke T; Saito N
Br J Pharmacol; 2006 May; 148(1):54-60. PubMed ID: 16520745
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of sepimostat mesilate prevents acute alcohol pancreatic injury in rats.
Yuasa C; Irimura K; Oda M; Fukui K; Oka T
J Pharm Pharmacol; 1999 Jul; 51(7):867-71. PubMed ID: 10467964
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
[TBL] [Abstract][Full Text] [Related]
6. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
7. Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.
Emori Y; Mizushima T; Matsumura N; Ochi K; Tanioka H; Shirahige A; Ichimura M; Shinji T; Koide N; Tanimoto M
J Gastroenterol Hepatol; 2005 Jun; 20(6):895-9. PubMed ID: 15946137
[TBL] [Abstract][Full Text] [Related]
8. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of bradykinin receptors is implicated in the pain associated with caerulein-induced acute pancreatitis.
Takemura Y; Furuta S; Hirayama S; Miyashita K; Imai S; Narita M; Kuzumaki N; Tsukiyama Y; Yamazaki M; Suzuki T; Narita M
Synapse; 2011 Jul; 65(7):608-16. PubMed ID: 21484880
[TBL] [Abstract][Full Text] [Related]
10. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
[TBL] [Abstract][Full Text] [Related]
11. [Camostat mesilate, a protease inhibitor, inhibits visceral sensitivity and spinal c-fos expression in rats with acute restraint stress].
Zhao J; Wang Z; Zou B; Song Y; Dong L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1546-50. PubMed ID: 25345960
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice.
Tashiro M; Samuelson LC; Liddle RA; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G784-90. PubMed ID: 14684381
[TBL] [Abstract][Full Text] [Related]
13. Synthetic antiproteases in acute pancreatitis: an experimental study.
Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
[TBL] [Abstract][Full Text] [Related]
14. Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Ishizaki M
J Lab Clin Med; 1990 Aug; 116(2):206-10. PubMed ID: 2394938
[TBL] [Abstract][Full Text] [Related]
15. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
[TBL] [Abstract][Full Text] [Related]
16. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
Lee IO; Seo Y
Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
[TBL] [Abstract][Full Text] [Related]
17. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
Gibo J; Ito T; Kawabe K; Hisano T; Inoue M; Fujimori N; Oono T; Arita Y; Nawata H
Lab Invest; 2005 Jan; 85(1):75-89. PubMed ID: 15531908
[TBL] [Abstract][Full Text] [Related]
18. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity.
Kono K; Takahashi A; Sugai H; Umekawa T; Yano T; Kamiyasu K; Teramatsu M; Fujii H
Am J Surg; 2005 Sep; 190(3):412-7. PubMed ID: 16105528
[TBL] [Abstract][Full Text] [Related]
19. Increase of 200-kDa neurofilament-immunoreactive afferents in the substantia gelatinosa in allodynic rats induced by compression of the dorsal root ganglion.
Watanabe K; Konno S; Sekiguchi M; Sasaki N; Honda T; Kikuchi S
Spine (Phila Pa 1976); 2007 May; 32(12):1265-71. PubMed ID: 17515813
[TBL] [Abstract][Full Text] [Related]
20. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat.
Raboin SJ; Reeve JR; Cooper MS; Green GM; Sayegh AI
Regul Pept; 2008 Oct; 150(1-3):73-80. PubMed ID: 18620003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
